Of the patient to long-acting beta-2 agonist treatment by analyzing polymorphisms in the beta2-adrenergic receptor gene and to identify the patient as a candidate for the treatment with long-acting beta agonist Method for predicting the response

摘要

Comprising identifying the presence or absence of a haplotype at least one C in the beta2-adrenergic receptor gene and that isolating a biological sample from the patient, the present invention is a long-acting beta agonist relates to a method for identifying a patient as a candidate for the treatment of. The presence of haplotype C one, indicates that the patient is a good candidate for the treatment at least in the patient samples. For example, the patient respiratory diseases, obstructive airway disease, and preferably may have asthma, COPD or most preferably. The present invention relates to a method for predicting the response of asthmatic patients to long-acting beta-2 agonist therapy comprising detecting polymorphisms in the beta2-adrenergic receptor gene.